AstraZeneca sticks to $80 billion sales target for 2030
- Posted on July 27, 2026
- By The Times
- 0 Views
- 1 min read
In brief
Generating AI summary…
AstraZeneca sticks to $80 billion sales target for 2030
Sir Pascal Soriot, the chief executive of the pharmaceutical company, says the forecast ‘assumes successes and setbacks’ along the way, after drug trial setback